-
1
Correlation of HER2 expression and clinicopathological characteristics in patients with urothelial carcinoma in China
Published 2024-11-01Subjects: “…|urothelial carcinoma|human epidermal growth factor receptor 2|clinicopathological characteristics|china…”
Get full text
Article -
2
-
3
-
4
Expression of Her-2 and Ki-67 in Gastric Cancer Formalin Fixed Paraffin Embedded Tissue Blocks and Their Correlation with Histological Grades at the Uganda Cancer Institute Patholo...
Published 2024-12-01Subjects: “…human epidermal growth factor receptor 2…”
Get full text
Article -
5
Multi-sequence MRI-based nomogram for prediction of human epidermal growth factor receptor 2 expression in breast cancer
Published 2025-02-01Subjects: Get full text
Article -
6
Circ-0007766 acts as a miR-1972 sponge to promote breast cancer cell migration and invasion via upregulation of HER2
Published 2024-10-01Subjects: “…|breast cancer|human epidermal growth factor receptor 2|circ-0007766|mir-1972|metastasis…”
Get full text
Article -
7
A Real-World Comparison Between Adjuvant Docetaxel with Cyclophosphamide (TC) and Anthracycline–Taxane Chemotherapy in Early HER-2 Negative Breast Cancer
Published 2024-12-01Subjects: “…human epidermal growth factor receptor 2 negative…”
Get full text
Article -
8
Recognition of HER2 expression in hepatocellular carcinoma and its significance in postoperative tumor recurrence
Published 2019-03-01Subjects: Get full text
Article -
9
MRI-based machine learning radiomics for prediction of HER2 expression status in breast invasive ductal carcinoma
Published 2024-12-01Subjects: Get full text
Article -
10
Safety and Efficacy of Everolimus Plus Exemestane in Postmenopausal Women with Treatment-refractory Hormone Receptor-positive, Human Epidermal Growth Factor Receptor 2-negative Adv...
Published 2023-07-01Subjects: “…hormone receptor-positive human epidermal growth factor receptor 2-negative advanced breast cancer…”
Get full text
Article -
11
The Clinical Study of Intratumoral and Peritumoral Radiomics Based on DCE-MRI for HER-2 Positive and Low Expression Prediction in Breast Cancer
Published 2024-12-01Subjects: Get full text
Article -
12
Major pathologic response and long-term clinical benefit in hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer after neoadjuvant chemotherap...
Published 2024-12-01Subjects: “…Hormone receptor-positive/human epidermal growth factor receptor 2-negative breast cancer…”
Get full text
Article -
13
Clinical characteristics, metastasis patterns, and treatment outcomes of HER2-low breast cancer
Published 2025-02-01Subjects: “…HER2 (human epidermal growth factor receptor 2) status…”
Get full text
Article -
14
Quercetin inhibits truncated isoform of dopamine- and cAMP-regulated phosphoprotein as adjuvant treatment for trastuzumab therapy resistance in HER2-positive breast cancer
Published 2024-09-01Subjects: “…p95-human epidermal growth factor receptor 2 (her2)…”
Get full text
Article -
15
Targeting of the HER2/HER3 signaling axis overcomes ligand‐mediated resistance to trastuzumab in HER2‐positive breast cancer
Published 2019-03-01Subjects: Get full text
Article -
16
Characterisation of IGF-1 (rs7136446) and IL-6 (rs1800795) polymorphisms among breast cancer patients in western Algeria
Published 2024-10-01Subjects: Get full text
Article -
17
High Ki67 expression, HER2 overexpression, and low progesterone receptor levels in high-grade DCIS: significant associations with clinical practice implications
Published 2025-01-01Subjects: “…hormone receptors human epidermal growth factor receptor 2 (HER2)…”
Get full text
Article